Read from its own SEC filings · nothing written, nothing inferred

Intelligent Bio Solutions $INBS

🫧 Edgar looked up INTELLIGENT BIO SOLUTIONS INC. ($INBS). Last filing: 8-K (8.01 Other Events), 2026-09-11. 34 event filings (8-K) in the past twelve months.

🔖 Exposure: revenue $4.2M (FY2026). Experience: revenue up 38.1% on the year, up 76.2% a year over 4 years; operating margin -299.1%, up from -349.8%. Soundness: equity 46.1% of assets, return on equity -226.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $4.5M and $8.0M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -299.1% against a 1.2% median; growth 38.1% against 11.6%.

INTELLIGENT BIO SOLUTIONS INC. against its own record and its peers
Operating marginPeer median 1.2%-299.1%Revenue, on the yearPeer median 11.6%38.1%Equity of assetsPeer median 52.9%46.1%Return on equityPeer median -2.3%-226.3%Gold tick: the median of 55–59 peers with $50M+ revenue in surgical & medical instruments & apparatus

The figures, as filed

Fiscal year end2026-06-30
Revenue$4M
Revenue, on the year38.1%
Revenue, a year over the record76.2%
Operating margin−299.1%
Operating margin, prior year−349.8%
Net margin−295.8%
Research and developmentnot filed separately
Free cash flow−$12M
Cash$4M
Total debt
Equity of assets46.1%
Return on equity−226.3%
Payout of profit
Dividend per share
Audited years read5

Peers: the median of 60 filers with $50M+ revenue in surgical & medical instruments & apparatus.

Recent filings

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets, no buy or sell views. Figures from the SEC’s own data · every filing · this page as JSON · ask about another company

1 · Watch

Tell me when they file

Or tap watch on any row above. One note the day they file, from Edgar, each with a one-click stop link. Handled to EU GDPR and Japan APPI standards.

On Bluesky: follow Edgar & Edgarette.

2 · Price it

A new leader’s rebrand and launch

Priced live by the same engine as our estimator, from the catalogue at wholesale.

Price the printing · Open the full estimator

✦ Build the kit yourself
3 · Confirm

Check it with Jenny

Most buyers check what they found, or what their AI found, with one person before they commit. That person is the principal.

Jenny Huang Goodman MPA MSc MHSA, Principal

Book a time (757) 390-0424
Free · unsponsored · source-linked

Clean data. No ads. Not now, not later.

Nine boards reading every SEC filing the day it lands, ten editorial desks publishing daily, an open endpoint other AIs can query, and a 70,000-product house behind all of it. This is the public record end of it.

Every row is a filing.Straight from the company's own SEC document, linked. Nothing written, nothing inferred.
Nobody is watching you read.No ad trackers, no cookies from us. Our page counts are cookieless.
One email, one job.Watch a company and we hold that address for the alert alone. One tap ends it. Never sold, never shared.
The house pays for this.Corporate event programs, corporate supplies and branded merchandise, since 1997. That is what funds the desks, under the house's own vendor standards.
Free to reuse with credit · CC BY 4.0 · how the boards are built